Carboplatin–gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer-Reference-Cited by-同舟云学术

Carboplatin–gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer

Published:2011-12-27 Issue:1 Volume:18 Page:177-182
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Hashimoto Yasuhiro,Imanishi Kengo,Tokui Noriko,Okamoto Teppei,Okamoto Akiko,Hatakeyama Shingo,Yoneyama Takahiro,Koie Takuya,Kamimura Noritaka,Ohyama Chikara

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-011-0363-7.pdf

Reference19 articles.

1. Penning TM (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin Cancer Res 11:1687–1690

2. Kasajima H, Yamagishi S, Sugai S et al (2001) Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients. Virchows Arch 439:46–54

3. Oates PJ (2010) Aldose reductase inhibitors and diabetic kidney disease. Curr Opin Investig Drugs 11:402–417

4. Hwang YC, Kaneko M, Bakr S et al (2004) Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 18:1192–1199

5. Yagihashi S, Mizukami H, Ogasawara S et al (2010) The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice. J Pathol 220:530–541

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esterase-Responsive Fluorogenic Prodrugs of Aldose Reductase Inhibitor Epalrestat: An Innovative Strategy toward Enhanced Anticancer Activity;ACS Applied Bio Materials;2024-08-15

2. Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression;Journal of International Medical Research;2023-06

3. Aldose reductase and cancer metabolism: The master regulator in the limelight;Biochemical Pharmacology;2023-05

4. Overexpression of AKR1B10 Predicts Poor Prognosis in Gastric Cancer Patients Undergoing Surgical Resection;Current Oncology;2022-12-21

5. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling;Cell Death & Disease;2021-05-25